Know what breast cancer can look and feel like.2,3
Symptoms of breast cancer can include lumps or thickening of skin in the breast or underarm areas, changes in the size or shape of the breast, dimpling, puckering, scaly, red or swollen skin on any area of the breast, an inverted (turned inward) nipple, or leakage of fluid (especially bloody) from the nipple.
Find out if you're at risk:
Are you at risk for hereditary breast cancer?
Know the red flags associated with Hereditary Cancer.
Find out if you're at risk:
BRCA positive women who have had breast cancer ALSO have up to a 12.7% risk for ovarian cancer to develop within 10 years of their breast cancer diagnosis. Knowing this allows BRCA+ women to TAKE ACTION to help reduce the likelihood of ovarian cancer, following a breast cancer diagnosis.6
Find out if you're at risk:
Women of Ashkenazi Jewish heritage are at higher risk of having BRCA mutation. The U.S. Preventive Services Task Force recommends testing for BRCA mutations for Ashkenazi Jewish women if they have a first-degree relative with breast or ovarian cancer or two second-degree relatives on the same side of the family with breast or ovarian cancer.7
Find out if you're at risk:
In addition to BRCA1 and BRCA2, other genes can increase the risk for breast cancer. Learn more about these genes here.
Find out if you're at risk:
Medical guidelines recommend those at general population risk for breast cancer have regular screening. Beginning in the 20s, these include: clinical breast exam every 1-3 years, and self-awareness of breast changes.10
Beginning at ages 40-50 these include: annual clinical breast exams, annual mammograms, self-awareness of breast changes.10 For those at increased risk (e.g., >20% lifetime risk of breast cancer), the following screening changes may be warranted: clinical breast exams every 6-12 months, annual mammograms and MRIs beginning 10 years prior to the youngest age of diagnosis in the family but not less than age 30, breast awareness, and consideration of other risk reduction strategies.10
Individuals with greater breast cancer risk may require a more intensive medical management plan after consultation with your health care professional.
Find out if you're at risk:
Women at increased risk for breast cancer have risk-reducing options – such as risk-reducing medications (like tamoxifen and raloxifene) and risk-reducing surgeries (for example double mastectomy with reconstruction). These options should be discussed with a medical professional and considered based on a number of factors including personal history, family history and/or the identification of a gene mutation.11
Find out if you're at risk:
A family history of breast cancer is also important for men to know.
Not only could a hereditary breast cancer syndrome impact their female relatives, but men with certain genetic mutations are also at increased risk for cancers of the prostate, pancreas, and melanoma. Hear John’s journey after being diagnosed with Hereditary Breast and Ovarian Cancer Syndrome.
Find out if you're at risk:
There are many advocacy organizations that provide a community of support for women at all different stages of a breast cancer diagnosis or those who are finished with treatment and living their “new normal.” Click here for a list of resources that will empower patients and their families with information
Find out if you're at risk:
The first targeted therapy developed for breast cancer was Herceptin. It was approved for use in breast cancer by the FDA in 1998. Herceptin targets overexpression of the Her2 gene.17
The National Comprehensive Cancer Network (NCCN) recommends that all breast tumors be tested for Her2 status as part of the standard clinical workup.18
Find out if you're at risk:
In some cases, a double mastectomy can lower the chance of developing breast cancer to less than 10%.19
Read about Angelina Jolie-Pitt’s choice to have a risk-reducing double mastectomy after learning that she was positive for the BRCA1 gene mutation.
Find out if you're at risk:
Triple negative breast cancer (TNBC) accounts for about 15-20 percent of all breast cancers.20, 21 Some breast cancers test negative for 2 hormone (estrogen and progesterone) receptors and HER2 (a growth-promoting protein). These breast cancers are called triple negative breast cancer (TNBC).22
Testing negative for these three markers means commonly used hormone therapy and targeted drugs are typically not successful in treating these cancers. Chemotherapy may still be helpful. Women diagnosed with triple negative breast cancer before age 60 should be evaluated further for genetic risk.23
Find out if you're at risk:
Knowledge is power – talk to your doctor today about your personal or family history of breast cancer. Find a health care professional here.
Find out if you're at risk: